drug · small molecule
patient view →brincidofovir
Marketedupdated 2mo agoby SymBio Pharmaceuticals Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for smallpox and viral disease and 6 investigational indications.
targets
DNA polymerase
all catalysts(1)
phase 2 initiation · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that